Remove Documentation Remove Hospitals Remove Webinar
article thumbnail

Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (Video)

Drug Channels

I then document how five multi-billion-dollar, for-profit, publicly traded pharmacy chains and pharmacy benefit managers (PBMs)—Cigna (via Express Scripts), CVS Health, UnitedHealth Group (via OptumRx), and Walgreens, Walmart—continue to dominate the 340B contract pharmacy market. Click here if you can’t see the video below.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), takes place on Wednesday 16 th December, 11:00 GMT / 12:00 CET and will look at how to navigate the compliance pathway to increase patient engagement with clinical trials. Gaining patient input on marketing and recruitment materials.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Legal requirement, ethical duty: How to develop compliant, useful lay summaries

pharmaphorum

That was among the key messages from speakers at a joint European Forum for Good Clinical Practice (EFGCP) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) webinar, held last week. This should cover the entire process, “starting with the writing, the review of the document, and its dissemination”.

article thumbnail

Veterinary Medicine Outlook: 5 Changes and Trends Impacting Veterinary Practices

epicur

Some of the biggest changes that GFI #256 brings include: Increased documentation for patient-specific prescriptions Limitations to available 503A office-stock drugs Although veterinary professionals were aware of the impending changes with GFI for months, many have been left scrambling since it went into effect in April. Did you know?

article thumbnail

CDRH Seeks Public Comment on How to Increase Patient Access to At-Home Use Medical Technologies

FDA Law Blog: Biosimilars

As acknowledged in the Strategic Priorities document, certain demographic groups may have limited access to necessary treatments and diagnostics. For those who are interested in learning more about the decentralized clinical trial draft guidance, please check out the FDA’s webinar on June 20, 2023.

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

Clarify What Information is Sought from Speakers Report on Data Utilization Host Educational Webinars Before Listening Sessions Market as Stakeholder Listening Sessions if They Have Broader Representation Improve the Structure of the Listening Sessions. Finally, we encourage CMS to consider a longer time horizon for the submission of data.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

In a recent webinar from pharmaphorum, the National Institute for Health Research (NIHR) outlined why and how it has developed a new approach to engage with patients while complying with national regulations, such as those set out in the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice.